Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women

Christina A. Clarke(Menlo School), R. F. Ambinder(Johns Hopkins University), Sally L. Glaser, Risa B. Mann(Boston University), Ronald F. Dorfman(Stanford Medicine), Angela W. Prehn(Cancer Prevention Institute of California), Joseph A. DiGiuseppe(Hartford Hospital)

Cancer

January 1, 2001

10.1002/1097-0142(20010415)91:8<1579::aid-cncr1169>3.0.co;2-l

Cited by 61

Related Papers

Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases

|Cancer|1981|974

Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)

|Blood|2007|389

Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's Lymphoma

|New England Journal of Medicine|1992|326

Occurrence of breast cancer subtypes in adolescent and young adult women

|Breast Cancer Research|2012|286

Detection of ebv gene expression in reed‐sternberg cells of Hodgkin's disease

|International Journal of Cancer|1990|282